Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
41.82
+1.62 (4.03%)
Jul 31, 2026, 4:08 PM HKT

Sunshine Lake Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
272.44-207.431,99376.6-587.65
Depreciation & Amortization
461.93418.04391.27377.36259.82
Loss (Gain) From Sale of Assets
3.08-18.140.530.8219.07
Asset Writedown & Restructuring Costs
67.868.31485.39288.8425.98
Loss (Gain) From Sale of Investments
16.7-6.32-4.39-522.7-19.24
Loss (Gain) on Equity Investments
-0.25-0.6-0.22--
Stock-Based Compensation
258.67266.5545.14--
Other Operating Activities
238.15274.89165.311,084136.21
Change in Accounts Receivable
-121.131.44-1,418-530.59-216.1
Change in Inventory
-87.82-208.84-94.02-35.3398.57
Change in Accounts Payable
45.6-87.35109.49961.31-379.18
Operating Cash Flow
1,155500.531,6731,700-662.51
Operating Cash Flow Growth
130.79%-70.09%-1.57%--

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-836.04-1,062-343.72-570.07-356.29
Sale of Property, Plant & Equipment
1.8361.28-0.950.03
Sale (Purchase) of Intangibles
-84.73-163.3-251.36-283-223.4
Investment in Securities
-13.58-11.072,579-290-
Other Investing Activities
449.061,205-1,43021.95140.55
Investing Cash Flow
-483.4529.79554.57-1,120-439.11

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
2,6753,4802,164517.94444.96
Long-Term Debt Repaid
-2,503-4,306-3,454-1,146-157.68
Total Debt Repaid
-2,503-4,306-3,454-1,146-157.68
Net Debt Issued (Repaid)
172.73-825.69-1,290-628.22287.28
Repurchase of Common Stock
-19.18----
Common Dividends Paid
-584.43----
Other Financing Activities
-234.79-144.98-186.63-158.8-99.8
Financing Cash Flow
-665.67-970.67-1,477-787.03187.48

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.080.99-0.01-0.30.29
Net Cash Flow
5.99-439.35750.87-207.58-913.85

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
319.14-561.371,3291,130-1,019
Free Cash Flow Growth
--17.67%--
Free Cash Flow Margin
6.63%-13.97%21.12%30.17%-111.49%
Free Cash Flow Per Share
0.64-1.275.734.87-4.39
Levered Free Cash Flow
650.05982.841,067-2,703-616.5
Unlevered Free Cash Flow
793.931,1331,209-2,527-464.12

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
226.73111.68138.32112.7499.8
Cash Income Tax Paid
120.33247.64230.49255.43-18.62
Change in Working Capital
-163.35-294.76-1,402395.39-496.71